China SXT Pharmaceuticals (SXTC) Free Cash Flow (2018 - 2022)
Historic Free Cash Flow for China SXT Pharmaceuticals (SXTC) over the last 5 years, with Q3 2022 value amounting to -$343153.0.
- China SXT Pharmaceuticals' Free Cash Flow rose 429.93% to -$343153.0 in Q3 2022 from the same period last year, while for Sep 2022 it was -$343153.0, marking a year-over-year increase of 429.93%. This contributed to the annual value of -$2.3 million for FY2025, which is 2164.26% down from last year.
- As of Q3 2022, China SXT Pharmaceuticals' Free Cash Flow stood at -$343153.0, which was up 429.93% from -$363078.0 recorded in Q1 2022.
- China SXT Pharmaceuticals' Free Cash Flow's 5-year high stood at -$180000.0 during Q3 2019, with a 5-year trough of -$649235.0 in Q1 2019.
- Its 5-year average for Free Cash Flow is -$422670.0, with a median of -$360823.5 in 2021.
- Per our database at Business Quant, China SXT Pharmaceuticals' Free Cash Flow soared by 6857.6% in 2019 and then plummeted by 14970.22% in 2020.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Free Cash Flow stood at -$572811.0 in 2018, then skyrocketed by 68.58% to -$180000.0 in 2019, then crashed by 149.7% to -$449464.0 in 2020, then grew by 20.22% to -$358569.0 in 2021, then rose by 4.3% to -$343153.0 in 2022.
- Its Free Cash Flow stands at -$343153.0 for Q3 2022, versus -$363078.0 for Q1 2022 and -$358569.0 for Q3 2021.